Acrotech Biopharma Announces the Publication of Data From a Phase 1 Study of BELEODAQ ...

Retrieved on: 2021-04-26 13:52:30

Tags for this article:

Click the tags to see associated articles and topics

Acrotech Biopharma Announces the Publication of Data From a Phase 1 Study of BELEODAQ .... View article details on hiswai:

Excerpt

ORR was 86% with CR 71% in the Cohort treated at the MTD (1000 mg/m2 for 5 days). EAST WINDSOR, N.J.--(BUSINESS WIRE)-- Acrotech Biopharma ...

Article found on: www.biospace.com